The association between increased levels of GFAP and higher cognitive impairment in the AD group are in line with recent studies that posited specific reactive astrogliosis in AD and its correlation with the severity of cognitive impairment (Bettcher et al., 2021; Oeckl et al., 2022; Peretti et al., 2024). Here, GFAP is linked to Alzheimer disease.